论文部分内容阅读
从50年代末、60年代初开始,远距离~(60)钴、电子加速器的应用逐步取代了 X 线治疗机,因之显著地提高了恶性淋巴瘤的治愈率。Ⅰ、Ⅱ期何杰金病的5年生存率已达到85～90%,Ⅲ_A期70%,Ⅲ_B 期40～50%。非何杰金淋巴瘤放疗的5年生存率26～31.7%,Ⅰ、Ⅱ期可达到47～51%。目前多数学者认为,Ⅰ,Ⅱ期患者以放射治疗为主,Ⅲ_A 以放疗加化疗,Ⅲ_B、N 期以化疗为主,若化疗后尚有残存病灶可加放疗。也有人提出根据病理
Since the late 1950s and early 1960s, the application of long-range cobalt (60) cobalt and electron accelerators has gradually replaced the X-ray machine, which has significantly improved the cure rate of malignant lymphoma. The five-year survival rate of Hodgkin’s disease in stage I and II has reached 85-90%, 70% in III_A stage and 40-50% in III_B stage. The 5-year survival rate of non-Hodgkin’s lymphoma is 26 to 31.7%, and I and II can reach 47 to 51%. At present, most scholars believe that stage I and II patients are mainly treated with radiation therapy, III_A is treated with radiotherapy and chemotherapy, and III_B and N are treated with chemotherapy. If there are residual lesions after chemotherapy, radiotherapy may be added. It was also proposed according to pathology